CHRU de Tours Hôpital Bretonneau

Tours 37044

1 studies enrolling now · 5 studies all time

What they study most

AML, Acute Kidney Injury Due to Sepsis, Chronic Lymphocytic Leukemia, Community-acquired Pneumonia, Diffuse Large B Cell Lymphoma, Idiopathic Pulmonary Fibrosis, Non Hodgkin Lymphoma

Studies at this site

• Safety and Efficacy of KRT-232 in Combination With Acalabrutinib in Subjects With R/R DLBCL or R/R CLL — Recruiting now
• A Phase 2 Study of CAL101 in Patients With Idiopathic Pulmonary Fibrosis — Running, not enrolling
• Safety and Efficacy of AON-D21 in Severe Community-Acquired Pneumonia. — Completed
• (Revival) Study to Investigate the Efficacy and Safety of Alkaline Phosphatase in Patients With Sepsis-Associated AKI — Stopped early
• Flotetuzumab in Primary Induction Failure (PIF) or Early Relapse (ER) Acute Myeloid Leukemia (AML) — Stopped early